Literature DB >> 19914428

Treatment of the patent ductus arteriosus: when, how, and for how long?

Shahab Noori, Istvan Seri.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19914428     DOI： 10.1016/j.jpeds.2009.07.053

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  3 in total

1.  Indomethacin for symptomatic patent ductus arteriosus in preterm infants.

Authors:  Peter Evans; Deirdre O'Reilly; Jonathan N Flyer; Roger Soll; Souvik Mitra
Journal:  Cochrane Database Syst Rev       Date:  2021-01-15

Review 2.  Renal Side Effects of Non-Steroidal Anti-Inflammatory Drugs in Neonates.

Authors:  Karel Allegaert; Jan De Hoon; Anne Debeer; Marc Gewillig
Journal:  Pharmaceuticals (Basel)       Date:  2010-02-03

3.  Effects of intravenous indomethacin on reduction of symptomatic patent ductus arteriosus cases and decreasing the need for prolonged mechanical ventilation.

Authors:  Abdollah Jannatdoust; Mahmoud Samadi; Saadollah Yeganehdoust; Mohammad Heydarzadeh; Hossein Alikhah; Reza Piri; Mohammad Naghavi-Behzad
Journal:  J Cardiovasc Thorac Res       Date:  2014-12-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.